These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9559027)
21. Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. Lusignan S; Sismanidis C; Carey IM; DeWilde S; Richards N; Cook DG BMC Fam Pract; 2005 Mar; 6(1):13. PubMed ID: 15784133 [TBL] [Abstract][Full Text] [Related]
22. The importance of postprandial glucose to treatments and outcomes in patients with type 2 diabetes. Herman ME; Moore RS Manag Care Interface; 2001 Nov; 14(11):63-9. PubMed ID: 11715766 [TBL] [Abstract][Full Text] [Related]
23. [Compliance to treatment and type 2 diabetes: impact on glycemic balance]. Guillausseau PJ Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029 [No Abstract] [Full Text] [Related]
25. [Current methods of glucose metabolism control in diabetes mellitus]. Scarpitta AM; Sinagra D Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998 [TBL] [Abstract][Full Text] [Related]
26. [Future perspectives in the treatment of type 2 diabetes]. Keller U Wien Klin Wochenschr; 2004 Apr; 116(7-8):213-4. PubMed ID: 15143858 [No Abstract] [Full Text] [Related]
28. [Pharmacologic treatment of diabetes]. De Montigny P; Clerc C; Descarpentries C Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094 [No Abstract] [Full Text] [Related]
29. Insulin therapy in the management of type 1 and type 2 diabetes. Wallymahmed M Nurs Stand; 2006 Oct 18-24; 21(6):50-6; quiz 58. PubMed ID: 17069159 [TBL] [Abstract][Full Text] [Related]
30. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus. Eledrisi M Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995 [No Abstract] [Full Text] [Related]
31. HbA1c in the Evaluation of Diabetes Mellitus. O'Keeffe DT; Maraka S; Rizza RA JAMA; 2016 Feb; 315(6):605-6. PubMed ID: 26864415 [No Abstract] [Full Text] [Related]
32. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA; Nathan MS; Beattie P Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816 [TBL] [Abstract][Full Text] [Related]
33. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus. Blonde L Am J Med; 2010 Mar; 123(3 Suppl):S12-8. PubMed ID: 20206727 [TBL] [Abstract][Full Text] [Related]
34. Women with Type 2 Diabetes and Glycemic Control. Gosse S Medsurg Nurs; 2014; 23(5):317-20, 329. PubMed ID: 26292437 [TBL] [Abstract][Full Text] [Related]
35. Insulin therapy, weight gain and prognosis. Hodish I Diabetes Obes Metab; 2018 Sep; 20(9):2085-2092. PubMed ID: 29785843 [TBL] [Abstract][Full Text] [Related]
38. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide]. Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597 [TBL] [Abstract][Full Text] [Related]
39. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office]. Fehmann HC Fortschr Med Orig; 2001 Jul; 119 Suppl 2():55-61. PubMed ID: 15704357 [TBL] [Abstract][Full Text] [Related]